English | Español
Patient Daily | Mar 17, 2026

Solid Biosciences reports new data for Duchenne gene therapy in Phase 1/2 trial
Patient Daily | Mar 17, 2026

Evaluate projects rare disease drug sales to surpass $400 billion by 2032
Patient Daily | Mar 17, 2026

Biotechs report regulatory challenges and key catalysts in fourth quarter earnings
Patient Daily | Mar 17, 2026

FDA transparency questioned after official’s anonymous comments on Huntington’s therapy
Patient Daily | Mar 17, 2026

Penn experts propose a tobacco playbook for food policy
Patient Daily | Mar 17, 2026

Preclinical study suggests new cream may slow or prevent some common skin cancers
Patient Daily | Mar 17, 2026

Study finds stress hormone cortisol impairs brain's navigation system
Patient Daily | Mar 17, 2026

GOLD and GLI release joint statement on spirometry use for COPD diagnosis

Trending
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Sarepta to seek full FDA approval for Duchenne therapies after failed confirmatory trial
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Lilly reports late-stage diabetes data for triple-G agonist retatrutide
+ Regulatory
Patient Daily | Mar 30, 2026

Freedom Foundation CEO Meeks on 340B: 'The program has morphed into a veritable ATM for hospitals'